Trials / Completed
CompletedNCT03786406
An International Survey of the Occurrence of Diseases That Affects the Heart and Blood Vessels Among People With Type 2 Diabetes
A Non-interventional Cross-sectional Study to Capture the Prevalence of Cardiovascular Disease in Patients With Type 2 Diabetes in Selected Countries in Europe
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,275 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to register the occurrence of cardiovascular disease among type 2 diabetes (T2DM) patients across five selected countries in Europe. Participants will be asked to give information about their health. Participants will continue their normal way of life and will not get any medication other than what has been prescribed to them by their doctor. Participants' participation will be one day/one visit at study doctor. The study will last for about 3 months in total.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No treatment given | No specific intervention is studied. All anti-diabetic and CV medication will be prescribed at the physician's discretion under routine clinical practice conditions. |
Timeline
- Start date
- 2018-12-03
- Primary completion
- 2019-05-31
- Completion
- 2019-05-31
- First posted
- 2018-12-26
- Last updated
- 2023-06-22
Locations
41 sites across 3 countries: Czechia, France, Italy
Source: ClinicalTrials.gov record NCT03786406. Inclusion in this directory is not an endorsement.